Expanded Access Program of Nintedanib in Patients With Idiopathic Pulmonary Fibrosis

NCT02230982 · clinicaltrials.gov ↗

NO_LONGER_AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

Idiopathic Pulmonary Fibrosis

Interventions

DRUG: nintedanib

Sponsor

Boehringer Ingelheim